Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031
PaperCitations, authors & open-access status
Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 562 citations, 2011 year and closed oa status.
562
Citations
2011
Year
closed
OA Status